The Efficacy and Safety of Chinese Medicine Fufang Zhenzhu Tiaozhi Capsule (FTZ) in the Treatment of Diabetic Coronary Heart Disease: Study Protocol for Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lexun Wang,1 Lei Xiang,1,2 Shenghua Piao,1 Xiao Gong,3 Wanxing Zhou,4 Weixun Feng,5 Huilin Li,6 Leyu Li,7 Aisheng Wei,8 Qing Zhu,1 Xianglu Rong,1 Jiao Guo1,2 1Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Min...
Guardado en:
Autores principales: | Wang L, Xiang L, Piao S, Gong X, Zhou W, Feng W, Li H, Li L, Wei A, Zhu Q, Rong X, Guo J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8968254a9d054c1693302c826cd381c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chinese Traditional Governing Approach: An Analysis from Ancient to Mao Zedong Politics
por: Maria Mukhtar, et al.
Publicado: (2020) -
Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial
por: Ying Cao, et al.
Publicado: (2021) -
Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer
por: Xiong J, et al.
Publicado: (2020) -
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
por: Zeng H, et al.
Publicado: (2021) -
Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
por: Xiaolin Tong, et al.
Publicado: (2018)